Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

Université Laval

$150,000.00

Investigating P2 Receptors in IBD Therapy: Mechanisms and Treatment Potential

EF 2024-25

Résumé
Supervisor's name: Jean Sévigny Institutions: Université Laval and Centre de Recherche du CHU de Québec - Université Laval Inflammatory Bowel Disease, which includes Crohn's disease and ulcerative colitis, is a condition that affects around 322,000 Canadians, causing chronic inflammation in the intestines. This inflammation leads to symptoms like severe pain, fatigue, and sleep problems. It can also increase the risk of mental health issues and increase the chance of developing colorectal cancer. Unfortunately, current treatments don't work for everyone, which is why new solutions are needed. Recent studies have shown that molecules in the body, called nucleotides (like ATP), are involved in inflammation by activating specific receptors in the gut. My research focuses on these receptors, called P2 receptors, precisely two of them, P2Y2 and P2Y6, which are believed to play a critical role in inflammation. I will study how blocking these receptors might reduce inflammation using mice models that closely mimic human disease. I will also use cells taken from the human intestine, normally discarded after surgery, to see if the findings from mice could lead to new treatments for people. My research will uncover a new aspect of how inflammation works, which will help us find better treatments to improve the lives of people with inflammatory bowel disease.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
517056
Name
ESPINDOLA GELSLEICHTER NICOLLY
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Investigating P2 Receptors in IBD Therapy: Mechanisms and Treatment Potential
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Clinical Samples; Colitis; Crohn Disease; Cytokines; Gastrointestinal Tract; Immune System; Inflammatory Bowel Disease; Murine Models; Nucleotides
Abstract
Supervisor's name: Jean Sévigny Institutions: Université Laval and Centre de Recherche du CHU de Québec - Université Laval Inflammatory Bowel Disease, which includes Crohn's disease and ulcerative colitis, is a condition that affects around 322,000 Canadians, causing chronic inflammation in the intestines. This inflammation leads to symptoms like severe pain, fatigue, and sleep problems. It can also increase the risk of mental health issues and increase the chance of developing colorectal cancer. Unfortunately, current treatments don't work for everyone, which is why new solutions are needed. Recent studies have shown that molecules in the body, called nucleotides (like ATP), are involved in inflammation by activating specific receptors in the gut. My research focuses on these receptors, called P2 receptors, precisely two of them, P2Y2 and P2Y6, which are believed to play a critical role in inflammation. I will study how blocking these receptors might reduce inflammation using mice models that closely mimic human disease. I will also use cells taken from the human intestine, normally discarded after surgery, to see if the findings from mice could lead to new treatments for people. My research will uncover a new aspect of how inflammation works, which will help us find better treatments to improve the lives of people with inflammatory bowel disease.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
ESPINDOLA GELSLEICHTER, NICOLLY
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~